{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:38:58Z","timestamp":1790519938805,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.vaccine.2004.08.050","type":"journal-article","created":{"date-parts":[[2004,11,4]],"date-time":"2004-11-04T13:28:30Z","timestamp":1099574910000},"page":"1507-1514","source":"Crossref","is-referenced-by-count":40,"title":["Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice"],"prefix":"10.1016","volume":"23","author":[{"given":"Tom\u00e1\u0161","family":"Hanke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"McMichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally A.","family":"Sharpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey A.J.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Crome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.08.050_bib1","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1586\/14760584.3.4.S89","article-title":"MVA as a vector for vaccines against HIV-1","volume":"3","author":"Im","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2004.08.050_bib2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2004.08.050_bib3","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2004.08.050_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line","volume":"238","author":"Carroll","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2004.08.050_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"Drexler","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2004.08.050_bib6","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2004.08.050_bib7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1128\/JVI.74.2.923-933.2000","article-title":"Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine","volume":"74","author":"Ramirez","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2004.08.050_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0264-410X(02)00403-6","article-title":"Lack of toxicity and persistence in the mouse associated with administration of candidate DNA- and modified vaccinia virus Ankara (MVA)-based HIV vaccines for Kenya","volume":"21","author":"Hanke","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.08.050_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00705-003-0006-z","article-title":"Tissue distribution of the Ankara strain of vaccinia virus (MVA) after mucosal or systemic administration","volume":"148","author":"Ramirez","year":"2003","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2004.08.050_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF01322704","article-title":"Studies on poxvirus infections in irradiated animals","volume":"64","author":"Werner","year":"1980","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2004.08.050_bib11","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/S0264-410X(02)00219-0","article-title":"Comparison of the efficacy of early versus late viral proteins in vaccination against SIV","volume":"20","author":"Stittelaar","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.08.050_bib12","first-page":"375","article-title":"Der Pockenimpfstamm MVA: Marker, genetische Struktur, Erfahrungen mit der parenteralen Schutzimpfung und Verhalten im abwehrgeschwachten Organismus","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl Bakt Hyg I [Abt Orig B]"},{"key":"10.1016\/j.vaccine.2004.08.050_bib13","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0264-410X(02)00771-5","article-title":"Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers","volume":"21","author":"Moorthy","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.08.050_bib14","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1086\/378515","article-title":"Safety and immunogenicity of DNA\/modified vaccinia virus Ankara malaria vaccination in African adults","volume":"188","author":"Moorthy","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2004.08.050_bib15","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1099\/vir.0.19701-0","article-title":"An HIV-1 clade A vaccine in clinical trials: Stimulation of HIV-specific T cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans","volume":"85","author":"Mwau","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2004.08.050_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0264-410X(03)00538-3","article-title":"Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals","volume":"22","author":"Cosma","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.08.050_bib17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/79626","article-title":"Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya","volume":"6","author":"Hanke","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2004.08.050_bib18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/aid.1997.13.923","article-title":"Anti-major histocompatibility complex antibody responses to simian B cells do not protect macaques against SIVmac infection","volume":"13","author":"Polyanskaya","year":"1997","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2004.08.050_bib19","series-title":"Animal Models in AIDS","first-page":"103","article-title":"SIV infection of rhesus macaques: in vivo titration of infectivity and development of an experimental vaccine","author":"Cranage","year":"1990"},{"key":"10.1016\/j.vaccine.2004.08.050_bib20","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1128\/JVI.73.9.7524-7532.1999","article-title":"Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen","volume":"73","author":"Hanke","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2004.08.050_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/088922201750063160","article-title":"Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA","volume":"17","author":"Leutenegger","year":"2001","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2004.08.050_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0264-410X(98)00238-2","article-title":"Effective induction of HIV-specific CTL by multi-epitope DNA using a gene gun in a combined vaccination regime","volume":"17","author":"Hanke","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.08.050_bib23","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1099\/0022-1317-82-9-2215","article-title":"Induction of simian immunodeficiency virus (SIV)-specific CTL in rhesus macaques by vaccination with modified vaccinia virus Ankara expressing SIV transgenes: influence of pre-existing anti-vector immunity","volume":"82","author":"Sharpe","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2004.08.050_bib24","series-title":"Contributions to statistical analysis","article-title":"Some k-sample rank-order tests","author":"Dwass","year":"1960"},{"key":"10.1016\/j.vaccine.2004.08.050_bib25","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1016\/S0264-410X(01)00075-5","article-title":"Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques","volume":"19","author":"Stittelaar","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.08.050_bib26","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1073\/pnas.262668999","article-title":"Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines","volume":"100","author":"Drexler","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2004.08.050_bib27","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2004.08.050_bib28","doi-asserted-by":"crossref","first-page":"4590","DOI":"10.1073\/pnas.0401165101","article-title":"Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge","volume":"101","author":"Wyatt","year":"2004","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04007133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04007133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T16:04:45Z","timestamp":1585929885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04007133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0264410X04007133"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.08.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}